Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page shows a minor site revision from v3.2.0 to v3.3.2 with no changes to trial data, study descriptions, or links. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the banner about government funding lapses and related operating status updates on the page.SummaryDifference0.8%

- Check42 days agoChange DetectedThe update shows minor visual adjustments to the Record History page and the version list; there are no changes to core trial data such as status, description, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference12%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

- Check93 days agoChange DetectedUpdated the page to Revision: v3.0.2, replacing v3.0.1; removed the 'Back to Top' element.SummaryDifference0.7%

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.